Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept

In the last decades, we have progressively observed an improvement in therapeutic options for metastatic colorectal cancer (mCRC) treatment with a progressive prolongation of survival. mCRC prognosis still remains poor with low percentage of 5-year survival. Targeted agents have improved results obt...

Descripción completa

Detalles Bibliográficos
Autores principales: Giordano, Guido, Febbraro, Antonio, Venditti, Michele, Campidoglio, Serena, Olivieri, Nunzio, Raieta, Katia, Parcesepe, Pietro, Imbriani, Giusy Carmen, Remo, Andrea, Pancione, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130202/
https://www.ncbi.nlm.nih.gov/pubmed/25136356
http://dx.doi.org/10.1155/2014/526178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130202/
https://www.ncbi.nlm.nih.gov/pubmed/25136356
http://dx.doi.org/10.1155/2014/526178

Ejemplares similares